Unknown

Dataset Information

0

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.


ABSTRACT: Low high-density lipoprotein (HDL)-cholesterol levels are associated with an increased risk of coronary artery disease (CAD) and myocardial infarction, which has triggered the hypothesis that HDL, in contrast to low-density lipoprotein (LDL), acts as an anti-atherogenic lipoprotein. Moreover, experimental studies have identified potential anti-atherogenic properties of HDL, including promotion of macrophage cholesterol efflux and direct endothelial-protective effects of HDL, such as stimulation of endothelial nitric oxide production and repair, anti-apoptotic, anti-inflammatory and anti-thrombotic properties. Studies in gene-targeted mice, however, have also indicated that increasing HDL-cholesterol plasma levels can either limit (e.g. apolipoprotein A-I) or accelerate (e.g. Scavenger receptor class B type I) atherosclerosis. Moreover, vascular effects of HDL have been observed to be heterogenous and are altered in patients with CAD or diabetes, a condition that has been termed 'HDL dysfunction'. These alterations in biological functions of HDL may need to be taken into account for HDL-targeted therapies and considering raising of HDL-cholesterol levels alone is likely not sufficient in this respect. It will therefore be important to further determine, which biological functions of HDL are critical for its anti-atherosclerotic properties, as well as how these can be measured and targeted.

SUBMITTER: Besler C 

PROVIDER: S-EPMC3376856 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.

Besler Christian C   Lüscher Thomas F TF   Landmesser Ulf U  

EMBO molecular medicine 20120316 4


Low high-density lipoprotein (HDL)-cholesterol levels are associated with an increased risk of coronary artery disease (CAD) and myocardial infarction, which has triggered the hypothesis that HDL, in contrast to low-density lipoprotein (LDL), acts as an anti-atherogenic lipoprotein. Moreover, experimental studies have identified potential anti-atherogenic properties of HDL, including promotion of macrophage cholesterol efflux and direct endothelial-protective effects of HDL, such as stimulation  ...[more]

Similar Datasets

| S-EPMC6113536 | biostudies-literature
| S-EPMC10053475 | biostudies-literature
| S-EPMC3722418 | biostudies-other
| S-EPMC6937204 | biostudies-literature
| S-EPMC5877920 | biostudies-other
| S-EPMC4761531 | biostudies-literature
| S-EPMC6699926 | biostudies-literature
| S-EPMC6121941 | biostudies-literature
| S-EPMC7879587 | biostudies-literature
| S-EPMC10727395 | biostudies-literature